Published in Brain Res on May 25, 1981
Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res (2008) 2.09
Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction. Trends Neurosci (2009) 2.09
Dynamic changes in accumbens dopamine correlate with learning during intracranial self-stimulation. Proc Natl Acad Sci U S A (2008) 1.77
Forebrain substrates of reward and motivation. J Comp Neurol (2005) 1.72
Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Rev (2007) 1.50
Operant self-stimulation of dopamine neurons in the substantia nigra. PLoS One (2013) 1.16
Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation. J Neurosci (2008) 1.15
Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philos Trans R Soc Lond B Biol Sci (2012) 0.96
Potential programming of dopaminergic circuits by early life stress. Psychopharmacology (Berl) (2010) 0.82
Cortical neurons multiplex reward-related signals along with sensory and motor information. Proc Natl Acad Sci U S A (2017) 0.75
Voluntary wheel running reduces voluntary consumption of ethanol in mice: identification of candidate genes through striatal gene expression profiling. Genes Brain Behav (2016) 0.75
A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42
Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature (2001) 5.14
Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis (1992) 4.19
Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest (2000) 3.75
The minimal important difference of exercise tests in severe COPD. Eur Respir J (2010) 3.27
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia (1973) 2.48
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol (1985) (1988) 2.34
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol (1985) (1988) 2.20
Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis (1991) 2.16
Associations of IL6 polymorphisms with lung function decline and COPD. Thorax (2009) 2.00
Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med (1996) 1.96
Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis (1991) 1.89
Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med (1994) 1.83
Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med (2000) 1.79
Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci (1981) 1.77
Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J (2008) 1.76
Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest (1993) 1.70
The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol (1988) 1.65
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science (1978) 1.59
Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis. Arthritis Rheum (1992) 1.59
Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA (1985) 1.57
Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci (1996) 1.53
Myasthenia gravis and upper airway obstruction. Chest (1996) 1.51
Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Crit Care Med (1995) 1.50
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science (1975) 1.49
Pulmonary function and respiratory chemosensitivity in moderately obese patients with sleep apnea. Chest (1993) 1.49
Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats. Psychopharmacology (Berl) (1976) 1.43
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area. J Neurosci (2000) 1.41
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol (1992) 1.41
Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine. Can J Psychol (1977) 1.38
Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther (1993) 1.38
Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology (Berl) (1995) 1.36
Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci (1994) 1.35
Catecholamine theories of reward: a critical review. Brain Res (1978) 1.35
Action of drugs of abuse on brain reward systems: an update with specific attention to opiates. Pharmacol Biochem Behav (1982) 1.34
Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats. Science (1976) 1.34
Determinants of maximal inspiratory pressure. The Baltimore Longitudinal Study of Aging. Am J Respir Crit Care Med (1998) 1.33
Persistent pneumomediastinum in interstitial fibrosis associated with rheumatoid arthritis: treatment with high-concentration oxygen. Chest (2000) 1.33
The effect of anthropometric and socioeconomic factors on the racial difference in lung function. Am J Respir Crit Care Med (2001) 1.29
Tracheal and neck position influence upper airway airflow dynamics by altering airway length. J Appl Physiol (1985) (1993) 1.28
Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: a moveable electrode mapping study. Brain Res (1980) 1.28
Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr (1984) 1.27
Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens. Synapse (1999) 1.26
Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: a variable dose paradigm. Pharmacol Biochem Behav (1989) 1.26
Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous D-amphetamine self-administration. J Neurosci (1999) 1.26
Mechanism of decreased left ventricular stroke volume during inspiration in man. Circulation (1984) 1.25
Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area. Eur J Neurosci (2001) 1.25
Incidence of lung cancer in systemic sclerosis. J Rheumatol (1985) 1.22
Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J Neurosci (1998) 1.21
Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway. Am Rev Respir Dis (1993) 1.18
The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol (2001) 1.16
Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav (1991) 1.15
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest (1998) 1.14
Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience (2001) 1.13
Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function. Lung Health Study Research Group. J Clin Epidemiol (1998) 1.13
Heroin reward is dependent on a dopaminergic substrate. Life Sci (1981) 1.10
Effect of positive nasal pressure on upper airway pressure-flow relationships. J Appl Physiol (1985) (1989) 1.10
Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology (Berl) (1996) 1.09
Impact of guinea worm disease on children in Nigeria. Am J Trop Med Hyg (1986) 1.08
Pimozide-induced extinction of intracranial self-stimulation: response patterns rule out motor or performance deficits. Brain Res (1976) 1.04
Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J Neurosci (2001) 1.04
Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science (1984) 1.03
Reflex modulation of airflow dynamics through the upper airway. J Appl Physiol (1985) (1994) 1.02
Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement. J Neurosci (1998) 1.01
Effects of abdominal pressure on venous return: abdominal vascular zone conditions. J Appl Physiol (1985) (1990) 1.01
Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol Biochem Behav (1989) 1.01
Treatment of capsulitis of the shoulder. Rheumatol Rehabil (1975) 1.01
Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J Neurosci (1994) 1.01
Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J (2009) 1.00
Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) (1984) 1.00
Mechanism of reduced LV afterload by systolic and diastolic positive pleural pressure. J Appl Physiol (1985) (1988) 0.99
Augmentation of cardiac function by elevation of intrathoracic pressure. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.99
Brain reward circuitry: four circuit elements "wired" in apparent series. Brain Res Bull (1984) 0.98
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med (1984) 0.97
Effect of lung inflation on lung blood volume and pulmonary venous flow. J Appl Physiol (1985) (1985) 0.96
Action of drugs of abuse on brain reward systems. Pharmacol Biochem Behav (1980) 0.96
Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats. Brain Res (1999) 0.96
Major attenuation of food reward with performance-sparing doses of pimozide in the rat. Can J Psychol (1978) 0.96
Quality assessment through patient self-report of symptoms prefiberoptic and postfiberoptic bronchoscopy. Chest (1998) 0.95
Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis. Hum Immunol (1997) 0.95
The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon. Chest (1982) 0.93
Assessment of occupational exposure to organophosphates in pest control operators. Am Ind Hyg Assoc J (1980) 0.93
Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment. J Pharmacol Exp Ther (1994) 0.93
Involvement of the ventral tegmental dopamine system in opioid and psychomotor stimulant reinforcement. NIDA Res Monogr (1986) 0.92
Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest (1996) 0.92
Effects of systolic and diastolic positive pleural pressure pulses with altered cardiac contractility. J Appl Physiol (1985) (1992) 0.92
Lateral hypothalamic electrical stimulation: does it make animals 'hungry'? Brain Res (1974) 0.92
Maximization of ethanol intake in the rat. Adv Exp Med Biol (1975) 0.91
Place preference conditioning with ventral tegmental injections of cytisine. Life Sci (1994) 0.91
Effects of naltrexone on nucleus accumbens, lateral hypothalamic and ventral tegmental self-stimulation rate-frequency functions. Brain Res (1988) 0.91
Alcohol preference in the laboratory rat induced by hypothalamic stimulation. Psychopharmacologia (1970) 0.91
Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Psychopharmacology (Berl) (2005) 0.90
Lung volume reduction surgery: is less really more? Am J Respir Crit Care Med (1999) 0.89
Influence of housing conditions on the acquisition of intravenous heroin and cocaine self-administration in rats. Pharmacol Biochem Behav (1989) 0.89
Brain substrates for reinforcement and drug self-administration. Prog Neuropsychopharmacol (1981) 0.89